Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant RecipientsJames A. Hutchinson, Fred Fändrich, Birgit Sawitzki et al.|The Journal of Immunology|2011Cited by 236
First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysisLutz Renders, Louis A. Matis|PLoS ONE|2019Cited by 59